Loading clinical trials...
Loading clinical trials...
Anti-VEGF intravitreal injections are the treatment of choice in age-related macular degeneration (AMD). However 37% of patients are unresponsive or poorly responsive to these therapies. It is still n...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Centre Hospitalier Universitaire de Nice
NCT07249216 · Age Related Macular Degeneration
NCT06787482 · Retinitis Pigmentosa (RP), Age Related Macular Degeneration, and more
NCT04697095 · Age Related Macular Degeneration
NCT02669953 · Age Related Macular Degeneration, Intravitreal Injections, and more
NCT06704009 · Wet Age Related Macular Degeneration, Wet AMD
Hôpital Pasteur 2 - Service d'Ophtalmologie
Nice
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions